DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (90)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 90   Next >>

Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Nausea, Pyrexia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Start date: 2012-07-01

Ribasphere

Ribavirin



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Belgium on 2012-08-23

Patient:

Reactions: Nasal Obstruction, Fatigue, Anaemia, Condition Aggravated, Pyrexia, Oropharyngeal Pain, Streptococcal Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-07-31

Rebetol
    Dosage: 1000 mg, bid
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-07-31

Victrelis
    Dosage: 2400 mg, tid
    Indication: Hepatitis C
    Start date: 2012-04-17
    End date: 2012-07-31



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-23

Patient:

Reactions: Abdominal Pain, Diarrhoea, Presyncope, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Rebetol
    Dosage: 1400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Other drugs received by patient: Wellbutrin; Acetylsalicylic Acid SRT; Nebivolol HCL; Gabapentin



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk, qw
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-07-25

Ribavirin
    Dosage: unk, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-07-25



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Stomatitis, Anaemia, Pyrexia, Rash, Drug Rash With Eosinophilia and Systemic Symptoms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Allopurinol
    Dosage: 100 mg, once
    Administration route: Oral
    End date: 2012-03-06

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-21

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-02-07
    End date: 2012-02-13

Rebetol
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-06

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-28

Other drugs received by patient: Magmitt



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-22

Patient:

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 microgram per kilogram
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-05-08

PEG-Intron
    Dosage: 1.5 microgram per kilogram
    Start date: 2012-05-23
    End date: 2012-07-18

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-02-26

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-03-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-05-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-07-24

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-05-02

Other drugs received by patient: Celestamine Combination; Loxonin; Famotidine; Celestamine Combination; Loxonin; Allopurinol



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded MK-5172
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Post Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded PRE Trial Therapy
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: f
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: h
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: c
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: g
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy

Blinded Therapy
    Dosage: e
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: d
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: b
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-04

Blinded Therapy
    Dosage: 4 df, tid
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-06-24

Blinded Therapy

Blinded Therapy

Blinded Therapy

Blinded Therapy
    Indication: Hepatitis C

Blinded Therapy

PEG-Intron
    Indication: Hepatitis C

PEG-Intron
    Dosage: 0.5 ml, qw
    Administration route: Oral
    Start date: 2012-01-10
    End date: 2012-06-19

Peginterferon Alfa-2B
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Placebo
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-04-10

Rebetol
    Dosage: 3 df, qpm
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-06

Rebetol
    Dosage: 2 df, qpm
    Administration route: Oral
    Start date: 2012-04-07
    End date: 2012-06-24

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-06-24

Rebetol
    Dosage: 3 df, qam
    Administration route: Oral
    Start date: 2012-04-17
    End date: 2012-04-30

Rebetol
    Dosage: 2 df, qam
    Administration route: Oral
    Start date: 2012-04-11
    End date: 2012-04-16

Ribavirin
    Dosage: a
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-04-04

Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril



Possible PEG-Intron side effects in

Reported by a physician from Spain on 2012-08-22

Patient:

Reactions: Drug Ineffective, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms

Drug(s) suspected as cause:
Intron A
    Dosage: unk
    Start date: 1999-01-01

Intron A
    Dosage: 3 mu, tiw
    Start date: 1992-09-01
    End date: 1993-03-01

Intron A
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-06

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 2012-02-01
    End date: 2012-03-13

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 1994-03-01

Ribavirin
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Ribavirin
    Dosage: unk
    Start date: 1999-01-01

Telaprevir
    Dosage: 750 mg, q8h
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-10

Other drugs received by patient: Verapamil; Trandolapril; Moxonidine; Telmisartan



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-15

Patient:

Reactions: Haemoglobin Decreased, Heart Rate Decreased, Pyrexia, Blood Pressure Decreased, Renal Failure Acute

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-18

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Other drugs received by patient: Digoxin; Losartan Potassium and Hydrochlorothiazide; Warfarin Sodium; Bisoprolol Fumarate; Lasix; Coniel; Warfarin Sodium; Bisoprolol Fumarate; Losartan Potassium and Hydrochlorothiazide; Digoxin; Losartan Potassium and Hydrochlorothiazide; Lasix; Coniel



Possible PEG-Intron side effects in

Reported by a physician from Italy on 2012-08-14

Patient:

Reactions: Abdominal Pain, Diarrhoea, Presyncope, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Rebetol
    Dosage: 1400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-23
    End date: 2012-08-04

Other drugs received by patient: Wellbutrin; Pantoprazole Sodium; Nebivolol HCL; Gabapentin



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient:

Reactions: Pyrexia, Hyperhidrosis

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Abdominal Pain, Fatigue, Bone Pain, Ocular Hyperaemia, Pyrexia, Constipation

Drug(s) suspected as cause:
PEG-Intron
    Dosage: redipen,150 microgram per 0.5 ml ,4 syringe per pack

Rebetol
    Dosage: 200 mg, unk

Telaprevir
    Dosage: 375 mg, unk

Other drugs received by patient: Acetaminophen / Hydrocodone Bitartrate; Magnesia [milk OF]; Amitiza; Etodolac; Alka-Seltzer



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Pyrexia, Neutropenia, Neutrophil Count Decreased, Erythema, Thrombocytopenia, Oropharyngeal Discomfort, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.72 mcg/kg/week
    Start date: 2012-01-25
    End date: 2012-01-25

PEG-Intron
    Dosage: 100 mcg/week
    Start date: 2012-06-12
    End date: 2012-06-25

PEG-Intron
    Dosage: 1.45 mcg/kg/week
    Start date: 2012-06-12
    End date: 2012-06-12

PEG-Intron
    Dosage: 1.44 mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-25

Rebetol
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2012-06-12
    End date: 2012-06-25

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-25

Other drugs received by patient: Urso 250; Urso 250



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Pain, Polyuria, Headache, Pyrexia, Myalgia, Mood Altered, Neck Pain, Chest Pain, DRY Mouth, Breath Odour, Dizziness, Depression, Sinus Congestion, Nausea, Anaemia, Glucose Tolerance Impaired, Hypoaesthesia, Oropharyngeal Discomfort, Tremor, Mental Impairment, Sleep Disorder, Visual Impairment, Asthenia, Feeling Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-09

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-03-09

Other drugs received by patient: Valium; Advil; Xanax; Ambien



Possible PEG-Intron side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-08-07

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Weight Decreased, Drug Ineffective, Pain, Pyrexia, Skin Reaction, Abdominal Discomfort, Weight Increased, Vascular Rupture, Hallucination, Cutaneous Lupus Erythematosus, Cough, Nervousness, Anaemia, Rhinitis, Muscular Weakness, Aggression, Dysgeusia, Insomnia, Alopecia, Anal Haemorrhage, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-07-16

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-16
    End date: 2012-07-16



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-06

Patient:

Reactions: Dyspnoea, Retching, Nausea, Pyrexia, Constipation, Fatigue, Palpitations, Dizziness, Asthenia, Influenza Like Illness

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: 150 ?g, unknown
    Indication: Hepatitis C

Rebetol
    Dosage: 200 mg, unknown
    Indication: Hepatitis C

Other drugs received by patient: Estradiol (+) Norethindrone; Tylenol (Caplet); Neupogen; Prochlorperazine; Procrit; Prozac



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Greece on 2012-08-01

Patient:

Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03

Rebetol
    Dosage: 1200 mg, unk
    Indication: Hepatitis C
    Start date: 2011-09-20
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient:

Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qd

Pegasys
    Dosage: 180mcg,once a week

Rebetol
    Dosage: 1200 mg, qd

Victrelis
    Dosage: 200mg,4tablets,three times a day

Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Japan on 2012-07-31

Patient:

Reactions: Drug Eruption, Pyrexia, Erythema Multiforme, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-05-09

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-14

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-05-17

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-03-29

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-12

Telavic
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-14

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-15
    End date: 2012-05-09

Other drugs received by patient: Prednisolone; Prednisolone; Diclofenac Sodium; Betamethasone; Clobetasol Propionate; Olopatadine HCL; Prednisolone; Prednisolone; Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Streptococcus Faec; Biofermin (Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Strepto



Possible PEG-Intron side effects in 75 year old male

Reported by a individual with unspecified qualification from Japan on 2012-07-31

Patient: 75 year old male

Reactions: Rhabdomyolysis, Henoch-Schonlein Purpura, Platelet Count Decreased, Oropharyngeal Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: dosage is uncertain.
    Indication: Hepatitis C
    Start date: 2006-12-01

Rebetol
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2006-12-01



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-27



Possible PEG-Intron side effects in 54 year old female

Reported by a pharmacist from United States on 2012-07-27

Patient: 54 year old female, weighing 113.5 kg (249.7 pounds)

Reactions: Nausea, Chills, Urinary Tract Infection, Pyrexia, Hyperhidrosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Paxil; Ibuprofen; M.v.i.; Ferrous Sulfate TAB; Ribavirin; Tylenol



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-27

Patient:

Reactions: Bedridden, Chest Discomfort, Vomiting, Nausea, Retching, Anaemia, Oropharyngeal Pain, Pyrexia, DRY Skin, Anxiety, Weight Increased, Thinking Abnormal, Dehydration

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-31

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-31

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-28



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-26

Patient:

Reactions: Pyrexia, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, unk
    Indication: Hepatitis C
    Start date: 2012-01-01

Rebetol



Possible PEG-Intron side effects in

Reported by a physician from Greece on 2012-07-24

Patient:

Reactions: Dyspnoea, Fatigue, Pleural Effusion, Pulmonary Embolism, Pyrexia, Cardiac Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 unk, unk
    Indication: Hepatitis C
    End date: 2012-07-03

Rebetol
    Dosage: 1200 microgram, unk
    Indication: Hepatitis C
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a physician from Spain on 2012-07-20

Patient:

Reactions: Drug Ineffective, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms

Drug(s) suspected as cause:
Intron A
    Dosage: unk
    Start date: 1999-01-01

Intron A
    Dosage: 6 miu, tiw, lymphoblastoid injection
    Start date: 1993-01-01

Intron A
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Intron A
    Dosage: 3 mu, tiw
    Indication: Hepatitis C
    Start date: 1992-09-01
    End date: 1993-03-01

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-06

Rebetol
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 1994-03-01

Rebetol
    Dosage: unk
    Start date: 1999-01-01

Rebetol
    Dosage: 1200 mg, qd
    Start date: 2012-02-01
    End date: 2012-03-13

Rebetol
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Telaprevir
    Dosage: 750 mg, q8h
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-10

Other drugs received by patient: Moxonidine; Verapamil; Telmisartan; Trandolapril



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-07-17

Patient:

Reactions: Neutropenia, Pyrexia, Thrombocytopenia, Erythema, Neutrophil Count Decreased, Oropharyngeal Discomfort, Leukopenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.72 mcg/kg/week
    Start date: 2012-01-25
    End date: 2012-01-25

PEG-Intron
    Dosage: 100 mcg/week
    Start date: 2012-06-12
    End date: 2012-06-25

PEG-Intron
    Dosage: 100 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-18

Rebetol
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2012-06-12
    End date: 2012-06-25

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-25

Telaprevir
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-11
    End date: 2012-01-25

Other drugs received by patient: Urso 250



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 57 year old female, weighing 85.7 kg (188.6 pounds)

Reactions: Night Sweats, White Blood Cell Count Decreased, Dyspnoea, Wheezing, Chills, Haemorrhoids, Anaemia, Laceration, Pyrexia, Joint Stiffness, Fatigue, Diverticulum, RED Blood Cell Count Decreased, Arthralgia, Impaired Healing, Insomnia, Dizziness, Injury, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 mcg once a week
    Indication: Hepatitis C

Pegasys
    Dosage: 180 mcg once a week
    Indication: Hepatitis C

Ribavirin
    Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
    Indication: Hepatitis C
    Start date: 2011-09-04

Ribavirin
    Dosage: 1200 mg/day, 1000 mg daily (400 mg am and 600 mg pm)
    Indication: Hepatitis C
    Start date: 2011-11-07

Victrelis
    Dosage: 200 mg 4 tabs three times a day orally
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21

Other drugs received by patient: Echinacea; Citalopram Hydrobromide; Milk Thistle; Zolpidem; Vitamin E; Omeprazole; Allegra-D 12 Hour



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: female

Reactions: Fatigue, Insomnia, Dizziness, Pyrexia, Blood Glucose Increased

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-06-06

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-06-06



Possible PEG-Intron side effects in 63 year old female

Reported by a physician from Japan on 2012-07-05

Patient: 63 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Hepatic Function Abnormal, Pruritus, Vomiting, Nausea, Anaemia, Alanine Aminotransferase Increased, Rash, Pyrexia, Hyperuricaemia, Aspartate Aminotransferase Increased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-02-09

Rebetol
    Dosage: 600 mg;qd;po 200 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-09
    End date: 2012-03-07

Rebetol
    Dosage: 600 mg;qd;po 200 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-08
    End date: 2012-04-19

Rebetol
    Dosage: 600 mg;qd;po 200 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-21

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-21

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-09
    End date: 2012-03-02

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-30
    End date: 2012-04-19

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-08
    End date: 2012-03-29

Other drugs received by patient: Rabeprazole Sodium; Allopurinol; Celestamine TAB



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012